DLB - Dolby Laboratories, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 57.3B
Enterprise Value 36.47B
Trailing P/E 36.64
Forward P/E 118.22
PEG Ratio (5 yr expected) 11.30
Price/Sales (ttm)5.93
Price/Book (mrq)3.13
Enterprise Value/Revenue 35.26
Enterprise Value/EBITDA 617.99

Trading Information

Stock Price History

Beta (5Y Monthly) 0.79
52-Week Change 310.66%
S&P500 52-Week Change 321.38%
52 Week High 372.54
52 Week Low 356.09
50-Day Moving Average 369.80
200-Day Moving Average 365.62

Share Statistics

Avg Vol (3 month) 3388.4k
Avg Vol (10 day) 3388.49k
Shares Outstanding 564.74M
Float 64.23M
% Held by Insiders 13.01%
% Held by Institutions 194.13%
Shares Short (Jan 30, 2020) 4596.39k
Short Ratio (Jan 30, 2020) 41.63
Short % of Float (Jan 30, 2020) 40.95%
Short % of Shares Outstanding (Jan 30, 2020) 40.59%
Shares Short (prior month Dec 30, 2019) 4387.56k

Dividends & Splits

Forward Annual Dividend Rate 40.88
Forward Annual Dividend Yield 41.22%
Trailing Annual Dividend Rate 30.82
Trailing Annual Dividend Yield 31.14%
5 Year Average Dividend Yield 41.02
Payout Ratio 439.90%
Dividend Date 3Feb 19, 2020
Ex-Dividend Date 4Feb 06, 2020
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep 26, 2019
Most Recent Quarter (mrq)Dec 26, 2019

Profitability

Profit Margin 16.71%
Operating Margin (ttm)22.27%

Management Effectiveness

Return on Assets (ttm)6.00%
Return on Equity (ttm)8.78%

Income Statement

Revenue (ttm)1.23B
Revenue Per Share (ttm)12.18
Quarterly Revenue Growth (yoy)-3.50%
Gross Profit (ttm)1.08B
EBITDA 359.55M
Net Income Avi to Common (ttm)205.68M
Diluted EPS (ttm)1.97
Quarterly Earnings Growth (yoy)-50.40%

Balance Sheet

Total Cash (mrq)911.66M
Total Cash Per Share (mrq)9.03
Total Debt (mrq)73.59M
Total Debt/Equity (mrq)3.15
Current Ratio (mrq)4.77
Book Value Per Share (mrq)23.13

Cash Flow Statement

Operating Cash Flow (ttm)301.88M
Levered Free Cash Flow (ttm)179.08M